Hospital Universitario La Paz, Madrid, España.
Emergencias. 2018 Jun;30(3):169-176.
To evaluate 5 diagnostic-therapeutic strategies for suspected acute paracetamol poisoning in terms of cost-effectiveness in a tertiary university hospital with an active, validated poisoning surveillance program (SAT-HULP).
Cost-effectiveness analysis of the 5 diagnostic-therapeutic alternatives considered when attending patients with suspected paracetamol poisoning. The alternatives were chosen by means of a decision tree. We studied patients detected by the SAT-HULP program between April 1, 2011, and January 31, 2015. The diagnostic-therapeutic alternatives were as follows: 1) systematic treatment of all patients with N-acetylcysteine (NAC), 2) NAC treatment according to the reported dose; 3) NAC treatment according to a Rümack-Matthew nomogram; 4) NAC treatment according to urine test results confirmed by a blood test, and 5) treatment according to elimination half-life calculation. Probability data were obtained from the SAT-HULP program and validation studies corresponding to the diagnostic tests. Deterministic and probabilistic sensitivity analyses were performed.
The approaches that were most cost-effective were those guided by reported doses and nomograms. The incremental cost-effectiveness of treatment according to reported dose was €5985.37. The sensitivity analysis showed that the model was highly dependent on variations in the main variables; the probabilistic sensitivity analysis indicated an incremental cost-effectiveness of €25 111.06 (SD, €1 534 420.16; range, €42 136.03-€92 358.75) between the first approach (treat all cases) and last (calculate elimination half-life); half-life calculation was the more efficient.
Treating according to nomogram was the most efficient diagnostic-therapeutic approach to treating paracetamol poisoning in our hospital. However, when the prevalence of paracetamol poisoning is higher and uncertainty is greater, it would be more efficient to treat based on calculating the half-life.
在一家拥有活跃、经过验证的中毒监测项目(SAT-HULP)的三级大学附属医院中,评估 5 种疑似急性对乙酰氨基酚中毒的诊断-治疗策略的成本效益。
对在就诊疑似对乙酰氨基酚中毒患者时所考虑的 5 种诊断-治疗替代方案进行成本效益分析。替代方案是通过决策树选择的。我们研究了 2011 年 4 月 1 日至 2015 年 1 月 31 日期间 SAT-HULP 项目所检测到的患者。诊断-治疗替代方案如下:1)对所有患者系统性给予 N-乙酰半胱氨酸(NAC)治疗,2)根据报告剂量给予 NAC 治疗,3)根据 Rümack-Matthew 列线图给予 NAC 治疗,4)根据血检确认的尿液检测结果给予 NAC 治疗,5)根据半衰期计算给予治疗。概率数据来自 SAT-HULP 项目和与诊断测试相对应的验证研究。进行了确定性和概率敏感性分析。
最具成本效益的方法是基于报告剂量和列线图的方法。根据报告剂量进行治疗的增量成本效益为 5985.37 欧元。敏感性分析表明,该模型高度依赖于主要变量的变化;概率敏感性分析表明,在第一种方法(治疗所有病例)和最后一种方法(计算半衰期)之间,增量成本效益为 25111.06 欧元(标准差,1534420.16 欧元;范围,42136.03-92358.75 欧元);半衰期计算法更有效。
在我们医院,根据列线图进行治疗是治疗对乙酰氨基酚中毒最有效的诊断-治疗方法。然而,当对乙酰氨基酚中毒的患病率较高且不确定性较大时,根据半衰期计算进行治疗将更为有效。